What is Travere Therapeutics, Inc.'s change in AP?

Travere Therapeutics, Inc. (TVTX) reported change in AP of -$11.81M in Q1 2026.

How has Travere Therapeutics, Inc.'s change in AP changed year-over-year?

Travere Therapeutics, Inc.'s change in AP decreased by 42.2% year-over-year, from -$8.31M to -$11.81M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Travere Therapeutics, Inc. TVTX Change in AP

Change in AP at other companies

Vertex PharmaceuticalsVRTX

$35.6M+35.9%

LQD

Liquidia CorporationLQDA

$562K-83.6%

BridgeBio PharmaBBIO

-$7.17M-141%

Arrowhead ResearchARWR

$15.26M+397%

PTC TherapeuticsPTCT

-$68.71M-471%

Scholar RockSRRK

-$1.09M+80.8%

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.13B+72.3%

Enterprise value$5.07B+65.5%

P/S9.6×-1.3×

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s change in AP?: Travere Therapeutics, Inc. (TVTX) reported change in AP of -$11.81M in Q1 2026.
How has Travere Therapeutics, Inc.'s change in AP changed year-over-year?: Travere Therapeutics, Inc.'s change in AP decreased by 42.2% year-over-year, from -$8.31M to -$11.81M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.